Psychedelic Research Bulletin: April 2023

Silo Pharma’s SPC-15 Awarded U.S. Patent Protecting Ongoing R&D of Therapeutic...

Delix Therapeutics Initiates Phase I Trial for Novel Compound DLX-001

Psychedelic Bulletin #137: Oregon Approves First Psilocybin Service Centre; AMA Approves...

FILAMENT HEALTH TO HOST VIRTUAL INVESTOR UPDATE

Clearmind Medicine Strengthens Scientific Advisory Board with Appointment of Prof. Joseph...

MIND CURE AND LNG ENERGY GROUP ENTER INTO ARRANGEMENT AGREEMENT WITH...

Algernon Pharmaceuticals Announces Closing of Rights Offering

Optimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical...

Psychedelics Weekly – Psychedelics and Sports, The Risks of Over-Regulation, and...

Load more